Management of Spontaneous Bacterial Peritonitis
Perform immediate diagnostic paracentesis without delay in all hospitalized cirrhotic patients with ascites, and start empirical IV antibiotics (cefotaxime 2g every 8-12 hours or ceftriaxone) immediately if ascitic neutrophil count >250/mm³, while simultaneously administering IV albumin to reduce mortality. 1, 2
Diagnostic Approach
When to Perform Paracentesis
Diagnostic paracentesis must be done urgently in:
- All cirrhotic patients with ascites on hospital admission (even without symptoms) 1, 2
- Patients with fever, abdominal pain/tenderness, or signs of systemic inflammation 1
- GI bleeding, shock, or hemodynamic instability 1
- Hepatic encephalopathy 1
- Worsening liver or renal function 1
- Unexplained acidosis or peripheral leukocytosis 3
Diagnostic Criteria
Ascitic neutrophil count >250/mm³ is the gold standard for SBP diagnosis and can be measured by manual microscopy or automated flow cytometry 1, 2. This threshold mandates immediate antibiotic treatment even before culture results return.
Inoculate at least 10mL of ascitic fluid into blood culture bottles at the bedside before starting antibiotics—this increases culture sensitivity to >90% 2. Obtain simultaneous blood cultures to maximize organism isolation 2.
Empirical Antibiotic Treatment
Community-Acquired SBP
Start IV cefotaxime 2g every 8 hours (or every 12 hours) or ceftriaxone as first-line therapy in community-acquired cases where multidrug-resistant organisms (MDROs) are not prevalent 1, 3, 2. These third-generation cephalosporins historically achieved ~90% resolution rates.
Healthcare-Associated or Nosocomial SBP
Consider broader-spectrum antibiotics (carbapenems) upfront in patients with:
- Nosocomial infection or recent hospitalization 2
- Prior antibiotic exposure 2
- Critically ill patients in ICU 2
- Septic shock (inappropriate initial therapy increases mortality 10-fold) 2
The shift toward gram-positive organisms and MDROs (now representing 35% of infections) has reduced cephalosporin efficacy, particularly in healthcare-associated cases 2, 4, 5. Carbapenems show higher resolution rates and lower mortality in nosocomial SBP 2.
Critical Caveat on Antibiotic Selection
Tailor antibiotic choice to local resistance patterns and institutional antibiograms—this is explicitly emphasized in the most recent guidelines 1. While cefotaxime remains widely studied, real-world data show initial treatment failure in up to 41% of cases due to resistant organisms 6.
Albumin Administration
Administer IV albumin 1.5g/kg within 6 hours of diagnosis, followed by 1g/kg on day 3 to prevent hepatorenal syndrome and reduce mortality. This intervention has markedly improved outcomes since its introduction 7, 8.
Monitoring Treatment Response
Consider repeat paracentesis at 48 hours if:
- Clinical response is inadequate 1
- Secondary bacterial peritonitis is suspected 1
- Ascitic PMN count should decrease by >25% with appropriate therapy 3, 6
In typical SBP with appropriate antibiotics, the 48-hour PMN count is essentially always below pretreatment values. Rising PMN counts despite treatment suggest secondary peritonitis requiring surgical evaluation 3.
Red Flags for Secondary Peritonitis
Order ascitic fluid total protein, LDH, and glucose if PMN >250/mm³. Secondary peritonitis is suggested by:
- Total protein >1g/dL
- LDH greater than upper limit of normal for serum
- Glucose <50 mg/dL
- Multiple organisms on culture 3
These patients need anaerobic coverage, imaging (CT scan, contrast studies), and surgical consultation 3.
Antibiotic Stewardship
Narrow antibiotic coverage as soon as culture results are available and treat for the shortest effective duration 2. The emerging MDRO threat makes stewardship critical—balance broad initial coverage with de-escalation based on susceptibilities.
Prophylaxis Strategies
Secondary Prophylaxis (After SBP Episode)
All patients recovering from SBP should receive long-term prophylaxis with:
- Norfloxacin 400mg once daily (preferred) 1
- Ciprofloxacin 500mg once daily (alternative, especially in UK where norfloxacin availability is limited) 1
- Co-trimoxazole 800mg/160mg once daily 1
Primary Prophylaxis
Offer primary prophylaxis to high-risk patients with ascitic protein <1.5g/dL, though communicate the risks/benefits and existing uncertainties 1. Evidence quality is low for this recommendation.
Patients with GI bleeding and ascites must receive prophylactic antibiotics (cefotaxime or per local protocol) to prevent SBP—this has strong evidence showing 32% infection reduction and 9% survival benefit 3, 1.
Important Prophylaxis Caveat
Carefully assess indications for long-term proton pump inhibitor use, as PPIs may increase SBP risk 1. Avoid unnecessary PPI continuation in patients on SBP prophylaxis.
Prognosis and Transplant Evaluation
SBP remains a major cause of hospitalization and mortality in cirrhosis 7, 4. Liver transplantation should be considered in all appropriate candidates after SBP, as this complication signals advanced disease with poor long-term prognosis 9.